IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $334,450 | -9.5% | 34,730 | 0.0% | 0.01% | -8.3% |
| Q2 2023 | $369,527 | +1.1% | 34,730 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $365,360 | +84867.4% | 34,730 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $430 | -99.9% | 34,730 | 0.0% | 0.02% | +7.1% |
| Q3 2022 | $360,000 | -10.0% | 34,730 | 0.0% | 0.01% | -6.7% |
| Q2 2022 | $400,000 | -8.5% | 34,730 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $437,000 | +7.9% | 34,730 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $405,000 | -12.0% | 34,730 | -1.4% | 0.01% | -36.8% |
| Q3 2021 | $460,000 | +2.9% | 35,235 | +1.5% | 0.02% | 0.0% |
| Q2 2021 | $447,000 | +15.2% | 34,730 | 0.0% | 0.02% | +11.8% |
| Q1 2021 | $388,000 | -2.0% | 34,730 | 0.0% | 0.02% | -5.6% |
| Q4 2020 | $396,000 | – | 34,730 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |